NCT06163443View on ClinicalTrials.gov

Evaluating the Impact of B Vitamin Supplementation (Soloways™) on Homocysteine and LDL-C Levels in Patients With MTHFR, MTR, and MTRR Polymorphisms.

NACompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

March 2, 2022

Primary Completion Date

February 13, 2023

Study Completion Date

May 1, 2023

Conditions
HyperhomocysteinemiaHyperlipoproteinemias
Interventions
DIETARY_SUPPLEMENT

Vitamin B

MTHFR, MTR, and MTRR polymorphysm based L-methylfolate (1 mg), P5P (pyridoxal-5-phosphate, 50 mg), and Methylcobalamin (500 mcg) prescription

DIETARY_SUPPLEMENT

Placebo

MTHFR, MTR, and MTRR polymorphysm based placebo prescription

Trial Locations (1)

630090

Center of New Medical Technologies, Novosibirsk

Sponsors
All Listed Sponsors
collaborator

Triangel Scientific

INDUSTRY

collaborator

Center of New Medical Technologies

OTHER

lead

S.LAB (SOLOWAYS)

OTHER